Currently, there is no staging system for acute lymphocytic leukemia (ALL).
Identifying Prognostic Factors
Since there is no staging system for ALL, oncologists focus on your individual features and features of the disease that help us better understand the natural history of the disease and the likelihood to respond to different therapies.
Today, with advances in research, diagnostic tools, and gene sequencing, cancer researchers and clinicians are getting a better picture of leukemia and its genetic markers and chromosomal abnormalities. With this knowledge, oncologists can determine what type of treatment a person with leukemia will best respond to, and as a result, will have a better chance of avoiding a relapse.
Precision genomic diagnostics can identify patients who might benefit from current, often cutting edge therapies, while sparing those who do not have a particular genetic signature from the costs and side effects of certain treatments.
Learn more about the Center for Personalized Diagnostics